Table 2.
Hematological analysis of untreated and treated mice with MFM501 at 300 mg/kg.
| Hematological analysis | MFM501 | |
|---|---|---|
| Untreated | 300 mg/kg | |
| WBC (×109/L) | 8.5 ± 3.7 | 7.1 ± 1.7 |
| Lymph (×109/L) | 6.6 ± 2.5 | 5.3 ± 1.2 |
| Mon (×109/L) | 0.3 ± 0.2 | 0.2 ± 0.1 |
| Gran (×109/L) | 1.6 ± 1.1 | 1.5 ± 0.6 |
| Lymph (%) | 78.4 ± 4.3 | 75.8 ± 6.9 |
| Mon (%) | 3.2 ± 0.7 | 3.1 ± 0.8 |
| Gran (%) | 18.3 ± 3.8 | 21.1 ± 6.4 |
| RBC (×1012/L) | 7.9 ± 0.3 | 8.4 ± 0.3 |
| HGB (g/dL) | 13.6 ± 0.5 | 13.7 ± 0.6 |
| HCT (%) | 39.1 ± 1.4 | 39.4 ± 2.5 |
| MCV (fL) | 49.5 ± 1.9 | 46.6 ± 2.3 |
| MCH (pg) | 17.1 ± 0.8 | 16.1 ± 0.5 |
| MCHC (g/dL) | 34.7 ± 0.2 | 34.7 ± 0.9 |
| RDW (%) | 16.5 ± 0.2 | 15.5 ± 1.4 |
| PLT (×109/L) | 753.6 ± 182.9 | 777.0 ± 114.4 |
| MPV (fL) | 4.5 ± 0.3 | 4.4 ± 0.2 |
| PWD | 16.4 ± 0.2 | 16.2 ± 0.3 |
| PCT (%) | 0.3 ± 0.1 | 0.3 ± 0.1 |
Values were expressed as mean ± standard deviation (SD) of five mice. p < 0.05 was considered statistically significant difference.